Yahoo Finance12. Aug. 2026
Guangzhou Wondfo Biotech Co Ltd - Product Pipeline Analysis, 2026 Update Now Available — 143-Page Review of All Pipeline Products by Equipment Type, Indication, and Development Stage
Opportunities include expanding rapid, molecular and automated diagnostics for clinical testing, chronic disease management, epidemic monitoring and personal health, plus market entry, partnerships, licensing and acquisitions around promising pipeline products.Dublin, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The "Guangzhou Wondfo Biotech Co Ltd (300482) - Product Pipeline Analysis, 2026 Update" has been added to ResearchAndMarkets.com's offering. Guangzhou Wondfo Biotech Co Ltd (Wondfo), headquartered
